BioSpace News Archive

FDA

Apic Bio’s APB-102 Receives Orphan Drug Designation from the FDA for the Treatment of Genetic SOD1 ALS

The U.S. FDA Orphan Drug program provides orphan designation to novel drugs that are intended for the treatment of rare diseases

July 22, 2019
·
3 min read
HAMLET Pharma Announces Results of First Major Clinical Trial for a New Cancer Killing Molecule

The novel therapeutic entity HAMLET is formed specifically when the human milk protein alpha-lactalbumin undergoes a conformational change and binds to oleic acid.

July 22, 2019
·
4 min read
Business

PharmaCyte Biotech and UTS Creating Advanced Version of Melligen Cells to Treat Diabetes

Research agreement with the University of Technology Sydney (UTS) in Australia to create a new version of Melligen cells for the treatment of diabetes with the potential to express higher levels of insulin.

July 22, 2019
·
8 min read
Global Bronchiectasis Drugs Market 2019-2023 | Advances in the Diagnostics of Respiratory Diseases to Boost Growth | Technavio

The global bronchiectasis drugs market is expected to post a CAGR close to 5% during the period 2019-2023, according to the latest market research report by Technavio.

July 22, 2019
·
4 min read
FDA

Baxter Announces U.S. FDA Approval of Myxredlin, The First and Only Ready-To-Use Insulin for IV Infusion

Offers extended shelf life of 30 days at room temperature or 24 months refrigerated

July 22, 2019
·
6 min read
Business

Zynex Expands Executive Team, Appoints Joseph Papandrea Chief Operating Officer

As COO Mr. Papandrea will lead operations including billing, patient support, sales and device production.

July 22, 2019
·
2 min read
BioCapital

FDA launches its first youth e-cigarette prevention TV ads, plans new educational resources as agency approaches one-year anniversary of public education campaign

“The Real Cost” Youth E-Cigarette Prevention Campaign aims to reach nearly 10.7 million at-risk youth through TV, digital platforms, social media, in-school ads and posters nationwide

July 22, 2019
·
7 min read
BioMidwest

Innovest Board Approves Plan to Maximize Shareholder Value from Biotech and Industrial Initiatives

Spin-Off of Biotechnology Effort will Result in Another Public Company, Which Will Feature Shares Owned by Innovest, and Paid Out as Dividends to IVST Stockholders

July 22, 2019
·
4 min read
Business

Water Street’s Partnership with Leading Medical Products Company Leads to FDA Approval of the First and Only Ready-to-Use Insulin for IV Infusion

It is the first and only ready-to-use insulin for IV infusion.

July 22, 2019
·
1 min read
Business

ENA to Induct Eight Members into Academy of Emergency Nursing

The Academy of Emergency Nursing honors emergency nurses who continue to advance the profession

July 22, 2019
·
2 min read